WO2019081040A1 - Contenant combiné pour emballer un liquide et une substance solide - Google Patents

Contenant combiné pour emballer un liquide et une substance solide

Info

Publication number
WO2019081040A1
WO2019081040A1 PCT/EP2017/077589 EP2017077589W WO2019081040A1 WO 2019081040 A1 WO2019081040 A1 WO 2019081040A1 EP 2017077589 W EP2017077589 W EP 2017077589W WO 2019081040 A1 WO2019081040 A1 WO 2019081040A1
Authority
WO
WIPO (PCT)
Prior art keywords
solid
liquid
dosage form
component
dietary supplement
Prior art date
Application number
PCT/EP2017/077589
Other languages
German (de)
English (en)
Inventor
Dorothee HARMS-GÄNSHIRT
Fred HARMS
Original Assignee
Beneganic GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beneganic GmbH filed Critical Beneganic GmbH
Priority to PCT/EP2017/077589 priority Critical patent/WO2019081040A1/fr
Publication of WO2019081040A1 publication Critical patent/WO2019081040A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00—Closures not otherwise provided for
    • B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
    • B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements

Definitions

  • the invention relates to a dosage form for a solid and liquid dietary supplement, which has a multivitamin complex, phytochemicals and product-specific active ingredients.
  • Dietary supplements are products sufficient to supply the human metabolism with certain z.T. essential nutrients or active substances at the interface between medicines and foods.
  • phytochemicals such as amygdalin (Löril) and chlorophyll. Although these compounds produced by plants do not play a vital role in the human organism, several studies, but an increasing number of scientific studies have shown secondary phytochemicals multiple health-promoting properties.
  • organic vitamins have an optimal effect and virtually no side effects, whereas artificial vitamin supplements may not only be less effective due to their incompleteness but also harmful to health.
  • synthetic vitamin preparations often contain chemicals, dyes, artificial sweeteners, aluminum, thickeners, synthetic antioxidants, flavors or even parabens.
  • Organic vitamins and minerals can only be extracted in complex processes, and especially an enrichment of the essential vitamins and minerals to an effective concentration is a challenge It is therefore an object of the present invention to provide a dietary supplement that ensures that the basic requirement is covered by natural vitamins, minerals and antioxidants, having a specific activity component and can be offered simultaneously in a single dosage.
  • the object of the invention is achieved by a device according to claim 1.
  • the dosage form according to the invention comprises a liquid component, a first solid component and a second solid component of a dietary supplement for human consumption.
  • the dietary supplement itself has a multivitamin complex, phytochemicals and product-specific drugs.
  • the multivitamin complex contains all the essential vitamins that the human body needs and essentially can not produce itself. These essential vitamins must therefore be supplied from outside through eg the food.
  • Dietary supplements can compensate for these deficiencies and provide the human body with all the important substances needed to maintain health or in the case of chronic diseases.
  • Secondary plant compounds such as polyphenols have multiple positive health effects; they can lower blood sugar and cholesterol or blood sugar levels, they have an anti-inflammatory effect, can protect the arteries from calcification, have a strong antioxidant effect and some can reduce the risk of cancer.
  • Product-specific active ingredients are added to the dosage form according to the invention in order to achieve a specific effect as desired by the user.
  • the product-specific active ingredients are essentially phytochemicals.
  • To counteract the aging of the human body for example, can be contained Q10 and omega-3 fatty acids that protect the skin and blood vessels of the human body.
  • the dosage form for example, green tea extract may be added as an antioxidant.
  • the first solid component is combined in a first capsule or tablet
  • the second solid component is in a second capsule or tablet.
  • the first capsule or tablet contains a multivitamin complex that the human body needs to maintain good health.
  • the second capsule or tablet may contain product-specific active ingredients which have a specific effect as desired by the user.
  • the liquid component to phytochemicals.
  • the secondary plant substances such as polyphenols in the liquid should have a preventive health effect.
  • the secondary plant substances have extracts of acerola and / or pomegranate.
  • the polyphenols of these two fruits in particular have a positive effect on blood sugar and cholesterol content and on inflammation and can reduce the risk of cancer.
  • the liquid component comprises at least 100 mg, preferably 500 mg and more preferably 750 mg phytochemicals.
  • the most preferred amount of 750 mg phytochemicals corresponds to the amount of polyphenols extractable from about 1 kg of pomegranates.
  • This high concentration in the liquid component ensures a positive effect on blood sugar and cholesterol levels as well as on inflammation and can reduce the risk of cancer.
  • the liquid component comprises a stabilizer. The stabilizer also stabilizes the active ingredients contained in the liquid component over a long period of time and thus ensures the effectiveness of the liquid component even after prolonged storage.
  • the stabilizer of the liquid component is vitamin C.
  • Vitamin C not only stabilizes the active ingredients in the liquid component but also has a positive effect on the immune system of the human body.
  • the stabilizer itself is also an active ingredient, additional stabilizers, e.g. Synthetically produced stabilizers are not necessary by this advantageous design.
  • the liquid component has a concentration of vitamin C in the amount of 1 g / l to 15 g / l.
  • Vitamin C has a strong taste that can be unpleasant in too high a concentration. Too high a concentration of vitamin C can lead to an unpleasant taste experience in the user when using the liquid component and tempt him to no longer use the liquid component. The correct choice of vitamin C concentration largely excludes this.
  • the first solid component comprises a multivitamin complex.
  • the multivitamin complex contains all the essential vitamins that the human body needs and essentially can not produce itself. These essential vitamins must therefore be administered externally by e.g. the food is fed.
  • the multivitamin complex is 100% of organic origin. It has been found that synthetically produced vitamins are not identical copies of naturally occurring vitamins. Synthetically produced vitamins differ in structure and composition from the naturally occurring organic originals. A naturally occurring vitamin usually consists of several components such as additional coenzymes and other cofactors, which only develop their positive effect in the human body when interacting. However, a synthetically produced vitamin is usually a single molecule and does not contain these additives. Its positive effect on the human body is therefore limited.
  • the multivitamin complex of organic origin used in the invention ie extracted from naturally occurring fruits, plants and medicinal herbs ensures by the interaction of vitamins and their components a positive effect on the human body. It has also been shown that synthetically produced vitamins can have a negative effect on the human body. Studies show, for example, increased cancer risk through the use of synthetically proven vitamins.
  • the multivitamin complex of organic origin used in the invention has an exclusively positive effect on the human body.
  • the secondary plant substances, the multivitamin complex, the minerals and / or the product-specific active ingredients are of purely organic origin.
  • the multivitamin complex comprises vitamins B5 and D. In a further optional embodiment of the invention, the multivitamin complex also contains the vitamins B1, B2, B3, B6, B7, B9, C, E and beta carotene.
  • the multivitamin complex contains minerals.
  • Essential minerals such as iron, zinc and selenium support blood formation, metabolism and bone or cartilage formation.
  • the minerals include calcium, phosphorus and / or potassium. These mineral substances are essential for bone structure and metabolism and can be supplied to the human body only from the outside.
  • the first solid component has at least 100 mg, preferably 200 mg and particularly preferably 300 mg minerals and / or multivitamin complex.
  • the second solid component has product-specific active ingredients. This embodiment simplifies the manufacturing process.
  • the liquid and the first solid components each have the same composition in each dose. Both components can therefore be produced inexpensively in a standardized process and packaged in a container.
  • the second solid component is supplied to the package after its manufacture. In this way dietary supplements may be combined with e.g. Antioxidant effect or to reduce the signs of aging compiled and labeled accordingly.
  • the product-specific active substances are effective for detoxification, for the protection of the immune system, for the protection of the skin and / or vascular health.
  • the specific active ingredients contained in the second solid component can therefore be combined and dosed depending on the effect desired by the user.
  • the product-specific active ingredients contain one or more active ingredients from the group of the constituents green tea extract, lycopene, omega-3 fatty acids and other antioxidants. These specific agents support the immune system and protect the human body from environmental pollutants by their antioxidant effect.
  • the second solid component has at least 50 mg, preferably 150 mg and particularly preferably 200 mg of product-specific active compounds.
  • the first solid component and the second solid component are optically distinguishable. Both solid components can be e.g. distinguished by their shape or color. This enables the user to reliably identify which component with which active ingredients it is consuming. Also in the manufacturing process it can be monitored in a simple manner that the placement of the dietary supplements has taken place in the intended form.
  • the dosage form according to the invention is packed with a liquid, a first solid and a second solid component in a combination container.
  • the combination container comprises a first container which is intended to receive the liquid component.
  • This first container can be closed by means of a screw cap.
  • the screw cap is designed so that it forms a second container for the two solid substances, which can be closed by a lid.
  • This embodiment of the combination container allows separate storage of the substances contained in the containers, but belonging together in the application.
  • a daily dosage is packaged in the combination container.
  • the intended common use of the associated substances is ensured with the combined storage in the combination container.
  • the mineral substances, the secondary plant substances and / or the product-specific active ingredients to 100% of organic origin.
  • Fig. 1 side view of the dosage form according to the invention in
  • Fig. 2 side view of the dosage form according to the invention in
  • the dosage form 1 comprises a liquid component 2, a first solid component 3 and a second solid component 4 in capsule and / or tablet form of a food supplement for human consumption.
  • the components are packaged in a combination box to allow for joint use of related components.
  • the combination container comprises a first container 6, which is intended to receive the liquid component 2.
  • This first container 6 is formed in bottle shape and closable by means of a screw cap 7.
  • the screw cap 7 is designed so that it forms a second container 8 for the two solid substances, the can be closed by a cover 5.
  • the nutritional supplement in this embodiment has the liquid component with highly enriched antioxidants, a first solid component with a multivitamin complex, and a second solid component with a specific drug complex for detoxifying the body and strengthening the immune system.
  • the liquid component 2 contains phytochemicals such as polyphenols of acerola and / or pomegranate, as well as the stabilizer vitamin C in a concentration of 9 g / l.
  • the first solid component 3 contains an organic-based multivitamin complex, that is, the vitamins are extracted from naturally grown plants.
  • the multivitamin complex contains all the essential vitamins that the human body needs and essentially can not produce itself.
  • the first solid component 3 contains vitamins B5 and D and minerals such as calcium, phosphorus and / or potassium.
  • the second solid component 4 is optically distinguishable from the first solid component 3 and contains product-specific active ingredients which are combined and dosed depending on the effect desired by the user.
  • the active ingredients of the second solid component 4 may contain anti-oxidants for detoxification, active substances that protect the immune system or contain active ingredients for the protection of the skin or vascular health.
  • the second solid component 4 contains agents containing antioxidants for detoxification. The exact composition is given in Tab. These specific active ingredients support the immune system and protect the human body from environmental pollutants by their antioxidant effect.
  • Table 1 Composition of the liquid, the first and the second solid component for the product "Immune & Detox": 1 shot, 1 capsule of vitamins, 1 capsule of green tea extract
  • Vitamin B2 (Ribof lavin 1 .89
  • Vitamin B3 (niacin) 45.77
  • Vitamin B9 (folic acid) 0.181
  • the container for the liquid component 2 is usually made of an aluminum alloy. Also possible is a solid plastic, eg PP, or glass. It is important in this context that the container is made opaque to ensure the durability of the liquid component 2 over a longer period of time.
  • the screw cap 7 consists of a solid plastic, as well as the lid 5, with which the screw cap 7 is closed, which simultaneously forms the container for the solid components.
  • the lid 5, with which the container of the solid Components can be safely closed, is dimensioned so that it can not solve the usual handling by the user. At the same time the lid 5 is to be removed with little effort.
  • FIG. 2 shows a dosage form 1 in a combination container containing two second solid components 4.
  • the amount of the specific active ingredients of the second solid component 4 can be so high, depending on the choice of the effect desired by the user, that the specific active ingredients are distributed over two capsules or tablets.
  • the capsules or tablets are easier to take and swallow by the user.
  • the dietary supplement in this embodiment has the liquid component with highly enriched antioxidants, a first solid component with a multivitamin complex and a second solid component with a specific active ingredient complex for reducing signs of aging (composition see Table 2).
  • the liquid component 2 with secondary plant substances is located in the bottle-shaped first container 6.
  • the second container 8 screws the first container 6 and contains the first 3 and the second solid component 4.
  • the first solid component 3 contains a multivitamin complex and minerals (composition s Table 2).
  • the second solid component 4 consists of two capsules or tablets and contains the specific active ingredients.
  • the lid 5 is attached to the second container 8.
  • Table 2 Composition of the liquid, the first and the second solid component for the product "Beauty Antiageing": 1 shot, 1 capsule of vitamins, 2 capsules of lycopene, Q10, omega3
  • Vitamin B1 (thiamine) 0,788
  • Vitamin B2 (Ribof lavin 0.823
  • Vitamin B3 (niacin) 19,98
  • Vitamin B9 (folic acid) 0.079
  • Vitamin B7 (biotin) 0.02
  • Vitamin B3 (niacin)
  • the second container 8 screws the first container 6 and simultaneously serves as a container for the first 3 and the second solid component 4.
  • the lid 5 is attached to the second container 8.
  • the first solid component 3 contains the multivitamin complex and Minerals (composition see Table 3).
  • the second solid component 4, 10 with the specific active ingredients consists of two capsules or tablets.
  • the first capsule or tablet of the second solid component 4 contains specific active ingredients for the reduction of signs of aging (composition see Table 3).
  • the second capsule or tablet of the second solid component 10 contains antioxidants for the detoxification of environmental pollutants (composition see Table 3). All three capsules or tablets 3, 4, 10 differ visually from each other, for example, by different shape and / or color or by the type (tablet or capsule). In this way, the user can reliably identify which component with which active ingredients it consumes.
  • Table 3 Composition of the liquid, the first and the second solid component for the product "Immune & Detox with Beauty Antiaging”: 1 shot, 1 capsule of vitamins, 1 capsule of lycopene, Q10, omega3 and 1 capsule of green tea extract

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une forme galénique d'un complément alimentaire solide et liquide, ce complément alimentaire présentant un complexe multivitaminé, des substances végétales secondaires et des principes actifs spécifiques au produit et comprenant un composant liquide, un premier composant solide et un deuxième composant solide.
PCT/EP2017/077589 2017-10-27 2017-10-27 Contenant combiné pour emballer un liquide et une substance solide WO2019081040A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2017/077589 WO2019081040A1 (fr) 2017-10-27 2017-10-27 Contenant combiné pour emballer un liquide et une substance solide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2017/077589 WO2019081040A1 (fr) 2017-10-27 2017-10-27 Contenant combiné pour emballer un liquide et une substance solide

Publications (1)

Publication Number Publication Date
WO2019081040A1 true WO2019081040A1 (fr) 2019-05-02

Family

ID=60413139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/077589 WO2019081040A1 (fr) 2017-10-27 2017-10-27 Contenant combiné pour emballer un liquide et une substance solide

Country Status (1)

Country Link
WO (1) WO2019081040A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053365A1 (en) * 2007-08-21 2009-02-26 Marni Markell Hurwitz Refreshment system having peel away nutrient and supplement packages
US20120040018A1 (en) * 2010-08-10 2012-02-16 Sure-Shot Medical Device Inc. Ingestible Supplement for Women

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053365A1 (en) * 2007-08-21 2009-02-26 Marni Markell Hurwitz Refreshment system having peel away nutrient and supplement packages
US20120040018A1 (en) * 2010-08-10 2012-02-16 Sure-Shot Medical Device Inc. Ingestible Supplement for Women

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "GNPD - Natural Tropical Burst Flavor Dietary Supplement", September 2017 (2017-09-01), pages 1 - 3, XP055442762, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/5119505/from_search/67vDvpMX5G/?page=1> [retrieved on 20180119] *
ANONYMOUS: "GNPD - Phytophanère Hydratation Supplement", March 2003 (2003-03-01), pages 1 - 2, XP055442485, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/196952/from_search/4NasPKju0o/?page=1> [retrieved on 20180119] *
ANONYMOUS: "GNPD - Total Skin and Body Supplements", March 2013 (2013-03-01), pages 1 - 3, XP055442771, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/1999665/from_search/67vDvpMX5G/?page=3> [retrieved on 20180119] *
ANONYMOUS: "GNPD - Vegetarian Multivitamin and Mineral Supplement", 31 January 2015 (2015-01-31), pages 1 - 2, XP055442768, Retrieved from the Internet <URL:http://www.gnpd.com/sinatra/recordpage/2922877/from_search/67vDvpMX5G/?page=3> [retrieved on 20180119] *
M JIMENEZ DEL RIO ET AL: "A new method of standartization of health-promoting pomegranate fruit (Punica granatum) extract.", GEORGIAN MEDICAL NEWS : MONTHLY REVIEWED JOURNAL, no. 11 (140), 1 November 2006 (2006-11-01), Tbilisi, Georgia (Republic), pages 70 - 77, XP055137003, ISSN: 1512-0112 *
MEZADRI T ET AL: "Antioxidant compounds and antioxidant activity in acerola (Malpighia emarginata DC.) fruits and derivatives", JOURNAL OF FOOD COMPOSITION AND ANALYSIS, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 4, June 2008 (2008-06-01), pages 282 - 290, XP022639956, ISSN: 0889-1575, [retrieved on 20080304], DOI: 10.1016/J.JFCA.2008.02.002 *

Similar Documents

Publication Publication Date Title
DE202007013532U1 (de) Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion
EP3503865A1 (fr) Préparation pour la repousse des cheveux ou complément alimentaire
WO2019081040A1 (fr) Contenant combiné pour emballer un liquide et une substance solide
DE202017106527U1 (de) Kombinationsbehältnis zur Verpackung einer Flüssigkeit und einer festen Substanz
EP3476757A1 (fr) Contenant combiné permettant d&#39;emballer un liquide et une substance solide
EP1616490A1 (fr) Composition comprenant de la lutéine, du zinc et du cuivre
EP2731454A1 (fr) Système diététique multi-composants
CA3153891A1 (fr) Compositions comprenant une fibre de peptide de soie de bombyx mori purifie et une huile de graines de buglossoides arvensis raffinee, et procedes associes
DE202015102038U1 (de) Koffeinhaltige Zusammensetzung
EP3111930A2 (fr) Composition pour le traitement de dépressions, de troubles bipolaires, de troubles dépressifs récidivants et d&#39;autres troubles affectifs persistants
EP1437051B1 (fr) Lutéine ocuvite
DE20320101U1 (de) Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
DE102014118772B4 (de) Nahrungsergänzungsmittel in Kapselform enthaltend chinesische Vitalpilze und deren Verwendung
LU501504B1 (de) Pulverförmiges nahrungsergänzungsmittel zur herstellung eines getränks
DE202005007462U1 (de) Nährstoffzusammensetzung für die Behandlung von chronischen Viruserkrankungen
AT17577U1 (de) Nahrungsergänzungsmittel mit Haferkrautextrakt
DE102022134337A1 (de) Zusammensetzung zur Aktivierung und/oder Stimulierung des limbischen Systems, diese enthaltende Kapsel oder Tablette sowie deren Verwendung als Nahrungsergänzungsmittel oder Arzneimittel
DE102006008003A1 (de) Kombinierte Darreichungsform u./o. Verpackungssystem für geschmacklich besonders geprägte Naturprodukte und weiterverarbeitete Naturprodukte u. ihre therapeutisch wirksamen Substanzen
DE202004005428U1 (de) Mikronährstoffkombinationsprodukt, geeignet für die nutritive Ergänzung bei einem erhöhten Bedarf an Mikronährstoffen insbesondere bei Personen mit Osteoporose
EP3263113A1 (fr) Utilisation et préparation destinés au maintien et à l&#39;amélioration des fonctions cognitives (comprenant colecalciferol, acide gras du omega-3 et ginkgo biloba)
DE102005022321A1 (de) Nährstoffzusammensetzung für die Behandlung von chronischen Viruserkrankungen
Erbguth et al. Ernährung und Nahrungsergänzungsmittel bei neurologischen Erkrankungen.
DE202010018383U1 (de) Rhodiolapräparat mit Zusätzen
AT13384U1 (de) Nahrungsergänzungsmittel
DOG et al. Dietary Supplements and Men’s Health

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17801355

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTS NACH REGEL 112(1) EPUE (EPA FORM 1205A VOM 30.06.2020)

122 Ep: pct application non-entry in european phase

Ref document number: 17801355

Country of ref document: EP

Kind code of ref document: A1